Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2018-03-16 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
ALS biomarker data presented at World CNS Summit
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content describes the presentation of biomarker data at a scientific summit ('6th World CNS Summit') and includes commentary from the Chief Scientific Officer. This is a corporate update regarding scientific progress and presentation activity, not a formal financial report (like 10-K or IR), a transcript (CT), or a dividend notice (DIV). Since it is a general announcement released via the RNS service that doesn't fit the more specific categories like ER, MANG, or CAP, it falls best under the general Regulatory Filings category (RNS), although it is essentially a press release detailing scientific achievements.
2018-03-16 English
Group of companies' accounts made up to 2017-09-30
Regulatory Filings
2018-03-16 English
Results of Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is announcing the "Results of Annual General Meeting". It details that all resolutions set out in the Notice of Annual General Meeting were duly passed by shareholders today (March 15, 2018). This directly corresponds to the definition of AGM Information (AGM-R). Although it is a result announcement, the content is the outcome of the meeting itself, not just an announcement that results will follow, making AGM-R more specific than RPA or RNS.
2018-03-15 English
Publication of Annual Report and Notice of AGM
Regulatory Filings Classification · 98% confidence The document is an RNS announcement (indicated by 'RNS Number : 9156E' and 'This information is provided by RNS'). The primary purpose of the announcement is the 'PUBLICATION OF ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 30 SEPTEMBER 2017 AND NOTICE OF ANNUAL GENERAL MEETING'. Since the document itself is a short announcement stating that the Annual Report and AGM Notice have been posted/made available, and it does not contain the full content of the Annual Report or the AGM materials, it fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' rule). It announces the publication of the Annual Report and the AGM details.
2018-02-15 English
Grant of Indian patent for EpiSwitch platform
Regulatory Filings Classification · 98% confidence The document is identified by an 'RNS Number' and contains an announcement from Oxford BioDynamics Plc dated February 14, 2018. The core subject is the 'grant of Indian patent for its proprietary technology platform, EpiSwitch™'. This is a specific corporate announcement regarding intellectual property (a patent grant) that does not fit into the primary financial reporting categories (10-K, IR, ER, etc.). Since it is a formal regulatory announcement disseminated via the RNS system, and it is not a general legal proceeding (LTR) or a management change (MANG), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2018-02-14 English
Shore Capital appointed as NOMAD and Sole Broker
Regulatory Filings Classification · 99% confidence The document is very short (2751 characters) and announces a specific corporate event: the appointment of Shore Capital as Nominated Adviser and Sole Broker. It is formatted as a regulatory news service release, indicated by the 'RNS Number' and the concluding line 'This information is provided by RNS The company news service from the London Stock Exchange'. Since this is a specific corporate announcement that doesn't fit into the defined categories like Director's Dealing (DIRS), Capital Change (CAP), or Dividend Notice (DIV), and it is not a report itself, it falls best under the general Regulatory Filings category (RNS) as a miscellaneous, timely announcement.
2018-01-30 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.